✦ LIBER ✦

Natural history of extended lamivudine (LAM) treatment in patients with HBeAg negative chronic hepatitis B (CHB)

✍ Scribed by Nicholas Tassopoulos; George Anagnostopoulos; Vana Sypsa; Johanna Delladetsima; Angelos Hantzakis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extended lamivudine treatment in patient

✍ Mario Rizzetto; Nicholas C. Tassopoulos; Robert D. Goldin; Rafael Esteban; Teres 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Adefovir dipivoxil (ADV) for the treatme

✍ F. Zoulim; C. Trepo; T. Poynard; S. Pol; J.P. Zarski; P. Marcellin; M. Beaugrand 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 153 KB

High rate of early posttreatment relapse

✍ O.S. Kwon; K.S. Byun; J.H. Kim; J.S. Kim; Y.T. Bak; J.E. Yeon; C.H. Lee 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 134 KB

10 HBV-DNA markers predictive of respons

✍ A. Ciancio; A. Smedile; M. Rizzetto; M. Lagget; A. Olivero; M.L. Abate; J. Gerin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Extended treatment with lamivudine and a

✍ Robert P. Perrillo; Hie-Won Hann; Eugene Schiff; David Mutimer; Bernard Willems; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 309 KB

Cost-effectiveness analysis of lamivudin

✍ M. BUTI; M. A. CASADO; J. L. CALLEJA; J. SALMERÓN; J. AGUILAR; M. RUEDA; R. ESTE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB